PATENT CLAIM ANALYSIS

Application Number: 16181628
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "001650"]

Abstract:
Among the various aspects of the present disclosure is the provision of compositions and methods for imaging and treating subjects with amyloidosis or multiple myeloma with or without amyloidosis.

Claim (Index 18):
The method of  claim 16 , comprising:\n adding a fixed amount of recombinantly expressed monomeric LC as substrate to seed from a biological sample; or amplifying the monomeric LC, resulting in amyloid, wherein LC aggregate is detected by direct detection by anti-amyloid nanoparticles of  claim 1  or amplification of amyloid through in vitro replication.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.30435
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13314160', '15026545', '12811049', '15552614', '15258883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6879209107120607
- 35 USC 102 Novelty (BERT): 0.4795962331766679
- Combined Prediction Score: 0.6670884429585214
- Mean Citation Score: 167.89954399999996
- Max Citation Score: 173.50372
- Similarity Product: 123.69733493479966

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test